Strong portfolio of IP for stem-cell expansion of Hematapoietic Stem Cells (HSC)
Significant competitive advantage in global market
Significant opportunities fromCytomatrix technologies:
Stem cell blood products
Bio Reactor technologies for range of stem cell applications
Short nanofiber production for broad range of industries
